Institutional investors purchased a net $7.0 million shares of CYTR during the quarter ended March 2017, and now own 18.12% of the total float, a percentage that is typical for companies in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SABBY CAPITAL LLC Bought 10.4 Million shares of CytRx Corp
RENAISSANCE TECHNOLOGIES LLC Bought 595.3 Thousand shares of CytRx Corp
BLACKROCK FUND ADVISORS Bought 484.8 Thousand shares of CytRx Corp